This compound is an Fmoc-protected amino acid derivative featuring a terminal alkene and a chiral center. It is primarily used as a building block in solid-phase peptide synthesis and pharmaceutical intermediate manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 288617-75-4
Fmoc-beta-Alanine
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-(1,3-dioxoisoindolin-2-yl)hexanoic acid
pharmaceutical intermediate
6-Azido-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-norleucine
pharmaceutical intermediate
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
pharmaceutical intermediate
Diazepam N-oxide
pharmaceutical intermediate
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
pharmaceutical intermediate
Lifitegrast Impurity 125
pharmaceutical intermediate
N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyldec-9-enoic acid
MADFVGMQNXRFAF-SANMLTNESA-N
C[C@](CCCCCCC=C)(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13